Aditya Bagrodia

Like I'm envisioning, you know, you still have your camera, obviously. You have your light core light source coming through. And then you've got your suctioning and aspirating channels, and then ability to work through one of those.

Like I'm envisioning, you know, you still have your camera, obviously. You have your light core light source coming through. And then you've got your suctioning and aspirating channels, and then ability to work through one of those.

So what's the overall French of the CVAC system?

So what's the overall French of the CVAC system?

So what's the overall French of the CVAC system?

And is the CVEC system, is that reusable? It's a single use. Single use. Yeah. Okay. So I think you walked us through, you know, the mechanics of it. I think getting an access sheath up or an accommodating ureter without an access sheath, then you kind of do the work. Compared and contrasted some of the pros and cons of fans, discs, and CVEC.

And is the CVEC system, is that reusable? It's a single use. Single use. Yeah. Okay. So I think you walked us through, you know, the mechanics of it. I think getting an access sheath up or an accommodating ureter without an access sheath, then you kind of do the work. Compared and contrasted some of the pros and cons of fans, discs, and CVEC.

And is the CVEC system, is that reusable? It's a single use. Single use. Yeah. Okay. So I think you walked us through, you know, the mechanics of it. I think getting an access sheath up or an accommodating ureter without an access sheath, then you kind of do the work. Compared and contrasted some of the pros and cons of fans, discs, and CVEC.

so i mean it all sounds compelling you know off the top of my head the main outcome of interest would be stone free rates as you've kind of outlined and then of course or times and then balancing that ostensible saving of over time with costs of a reusable you

so i mean it all sounds compelling you know off the top of my head the main outcome of interest would be stone free rates as you've kind of outlined and then of course or times and then balancing that ostensible saving of over time with costs of a reusable you

so i mean it all sounds compelling you know off the top of my head the main outcome of interest would be stone free rates as you've kind of outlined and then of course or times and then balancing that ostensible saving of over time with costs of a reusable you

Okay. What does the data show? It's safe. You've done it in pigs. You've done it in humans. Reported your first in man. You're not doing anything that's unexpected with a, you read Roscoe with an access sheet.

Okay. What does the data show? It's safe. You've done it in pigs. You've done it in humans. Reported your first in man. You're not doing anything that's unexpected with a, you read Roscoe with an access sheet.

Okay. What does the data show? It's safe. You've done it in pigs. You've done it in humans. Reported your first in man. You're not doing anything that's unexpected with a, you read Roscoe with an access sheet.

That's cool. I mean, it's kind of like a PSA recurrence predates a metastasis predates cancer specific survival. And I think it's expected that a stone free, a better stone free status helps mitigate some of these unpleasant, you know, reoperations, ER visits, pyelonephritis, etc. Yeah.

That's cool. I mean, it's kind of like a PSA recurrence predates a metastasis predates cancer specific survival. And I think it's expected that a stone free, a better stone free status helps mitigate some of these unpleasant, you know, reoperations, ER visits, pyelonephritis, etc. Yeah.

That's cool. I mean, it's kind of like a PSA recurrence predates a metastasis predates cancer specific survival. And I think it's expected that a stone free, a better stone free status helps mitigate some of these unpleasant, you know, reoperations, ER visits, pyelonephritis, etc. Yeah.

Yeah, not just the volume, but the surface texture, you know, is it jaggedy? Is it smooth? Does that impact passability? Yeah. Then, of course, the patient-specific factors, you know, is there ureter-like? Is there any evidence of X, Y, and Z? Sure.

Yeah, not just the volume, but the surface texture, you know, is it jaggedy? Is it smooth? Does that impact passability? Yeah. Then, of course, the patient-specific factors, you know, is there ureter-like? Is there any evidence of X, Y, and Z? Sure.

Yeah, not just the volume, but the surface texture, you know, is it jaggedy? Is it smooth? Does that impact passability? Yeah. Then, of course, the patient-specific factors, you know, is there ureter-like? Is there any evidence of X, Y, and Z? Sure.